Syljuåsen RG - Search Results

1

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy.

Halvorsen AR, Helland A, Fleischer T, Haug KM, Grenaker Alnaes GI, Nebdal D, Syljuåsen RG, Touleimat N, Busato F, Tost J, Saetersdal AB, Børresen-Dale AL, Kristensen V, Edvardsen H. Halvorsen AR, et al. Among authors: syljuasen rg. Int J Cancer. 2014 Nov 1;135(9):2085-95. doi: 10.1002/ijc.28862. Epub 2014 Apr 5. Int J Cancer. 2014. PMID: 24658971 Free PMC article.

2

Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI.

Halle C, Andersen E, Lando M, Aarnes EK, Hasvold G, Holden M, Syljuåsen RG, Sundfør K, Kristensen GB, Holm R, Malinen E, Lyng H. Halle C, et al. Among authors: syljuasen rg. Cancer Res. 2012 Oct 15;72(20):5285-95. doi: 10.1158/0008-5472.CAN-12-1085. Epub 2012 Aug 13. Cancer Res. 2012. PMID: 22890239

3

The efficacy of CHK1 inhibitors is not altered by hypoxia, but is enhanced after reoxygenation.

Hasvold G, Nähse-Kumpf V, Tkacz-Stachowska K, Rofstad EK, Syljuåsen RG. Hasvold G, et al. Among authors: syljuasen rg. Mol Cancer Ther. 2013 May;12(5):705-16. doi: 10.1158/1535-7163.MCT-12-0879. Epub 2013 May 1. Mol Cancer Ther. 2013. PMID: 23635654

4

Targeting lung cancer through inhibition of checkpoint kinases.

Syljuåsen RG, Hasvold G, Hauge S, Helland Å. Syljuåsen RG, et al. Front Genet. 2015 Feb 27;6:70. doi: 10.3389/fgene.2015.00070. eCollection 2015. Front Genet. 2015. PMID: 25774168 Free PMC article.

5

Protein phosphatase 1 regulators in DNA damage signaling.

Küntziger T, Landsverk HB, Collas P, Syljuåsen RG. Küntziger T, et al. Among authors: syljuasen rg. Cell Cycle. 2011 May 1;10(9):1356-62. doi: 10.4161/cc.10.9.15442. Epub 2011 May 1. Cell Cycle. 2011. PMID: 21451260 Review.

6

The amount of DNA damage needed to activate the radiation-induced G2 checkpoint varies between single cells.

Tkacz-Stachowska K, Lund-Andersen C, Velissarou A, Myklebust JH, Stokke T, Syljuåsen RG. Tkacz-Stachowska K, et al. Among authors: syljuasen rg. Radiother Oncol. 2011 Oct;101(1):24-7. doi: 10.1016/j.radonc.2011.05.060. Epub 2011 Jun 30. Radiother Oncol. 2011. PMID: 21722983

7

PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule.

Lund-Andersen C, Patzke S, Nähse-Kumpf V, Syljuåsen RG. Lund-Andersen C, et al. Among authors: syljuasen rg. Radiother Oncol. 2014 Feb;110(2):355-61. doi: 10.1016/j.radonc.2013.12.014. Epub 2014 Feb 4. Radiother Oncol. 2014. PMID: 24502970

8

Hypoxia-induced alterations of G2 checkpoint regulators.

Hasvold G, Lund-Andersen C, Lando M, Patzke S, Hauge S, Suo Z, Lyng H, Syljuåsen RG. Hasvold G, et al. Among authors: syljuasen rg. Mol Oncol. 2016 May;10(5):764-73. doi: 10.1016/j.molonc.2015.12.015. Epub 2016 Jan 8. Mol Oncol. 2016. PMID: 26791779 Free PMC article.

9

Expanding roles of cell cycle checkpoint inhibitors in radiation oncology.

Hauge S, Eek Mariampillai A, Rødland GE, Bay LTE, Landsverk HB, Syljuåsen RG. Hauge S, et al. Among authors: syljuasen rg. Int J Radiat Biol. 2023;99(6):941-950. doi: 10.1080/09553002.2021.1913529. Epub 2021 Apr 20. Int J Radiat Biol. 2023. PMID: 33877959 Review.

10

p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors.

Petersen L, Hasvold G, Lukas J, Bartek J, Syljuåsen RG. Petersen L, et al. Among authors: syljuasen rg. Cell Prolif. 2010 Aug;43(4):365-71. doi: 10.1111/j.1365-2184.2010.00685.x. Cell Prolif. 2010. PMID: 20590661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page